Repare Therapeutics
Repare is developing new, precision oncology drugs for patients that target specific vulnerabilities of tumor cells.
Launch date
Employees
Market cap
€136m
Enterprise valuation
(€51m) (Public information from Sep 2024)
Share price
$3.5 RPTX
Montreal Quebec (HQ)
Authorizing premium user...